Procaps Group SA (PROC) Operating Margin

Procaps Group Corp (PROC) - corporate logo

Procaps Group S.A. (PROC) brings together leading Latin American technologists, ensuring professional growth for its personnel. Business resilience is underpinned by an autonomous product cycle, transforming the asset into a reliable defensive tool. The history of operating margin changes demonstrates that the indicator stands at 0.00. Procaps Group S.A. (PROC) is scaling its CDMO production and iCaps capsule supplies, expanding its presence within the pharmaceutical holding segment.

Procaps (PROC): Operating Profit Margin from 07/04/2022 to 02/16/2025

Procaps Group S.A. - analytical breakdowns and key metrics (PROC)

- share price and consensus valuation forecast:
Analysis of all company metrics:PROC, Procaps Group SA
Brand item of Procaps Group Corp

High automation of Procaps Group S.A. pharmaceutical lines and robotic quality control minimize manual labor costs, directly impacting production efficiency. By analyzing the operating margin profile, an investor can see the share of profit from core activities in revenue before taxes and interest, which allows for the rapid screening of weak assets and an assessment of the business's fundamental stability.

Competitor analysis for Procaps Group S.A.

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability sxtchina.com|Operating Sales Margin Eupraxia Pharmaceuticals (EPRX)|Operating Margin BHST|EXOZ - Operating Return on Sales|Oramed - Operating Sales Margin|Entera Bio Ltd. (ENTX) - Operating Return on Sales|HYFT - Operating Profitability|ABVC: Operating Profitability|CPIX: Operating Margin|Quantum BioPharma Ltd. - Operating Profit Rate|FGEN (FibroGen Corp) - Operating Margin|Telomir Pharma (TELO) - Profitability of Operations|Operating Profitability Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operating Profit Rate|Operating Profitability Rallybio Corporation RLYB|LEXX: Return on Sales by Operating Profit|PULM - Operating Profitability|Operating Profit Rate PTHL (Pheton Holdings)|Aptorum (APM) - Operating Profitability|LYRA (Lyra Therapeutics) - Operating Profitability|Operating Profitability Impact BioMedical Inc|TNF Pharmaceuticals - Operating Profit Margin|Operating Margin YCBD|Operating Margin PainReform Ltd. (PRFX)|Operating Profitability Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Operating Profit Margin|OptiNose - Operating Margin|Operating Profit Margin PIRS|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.